For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Aventis Pharmaceuticals Products Inc.

USPTO Granted Patents = 23

Trademarks = 2

Forward Citations = 674

Loading Chart...

Loading Chart...

70 inventors (with patents filed for the assignee):

Alfred P Spada (6 out of 52 patents)

Benoit J Vanasse (6 out of 9 patents)

Scott I Klein (5 out of 21 patents)

4. Kevin Richard Guertin (4 out of 16 patents)

5. Adam W Sledeski (3 out of 9 patents)

6. Michael R Myers (3 out of 37 patents)

7. James P Sherbine (3 out of 7 patents)

8. Richard F Labaudiniere (3 out of 12 patents)

9. Patrick Leon (3 out of 24 patents)

10. Joseph M Salvino (2 out of 42 patents)

11. Wei He (2 out of 46 patents)

12. George C Morton (2 out of 22 patents)

13. Patrice Denefle (2 out of 18 patents)

14. Martin P Maguire (2 out of 24 patents)

15. Rick G Woodward (2 out of 4 patents)

23 patents: Sort by Forward Citations

1. 7041497 - Nuclear factor κB inducing factor (2006-05-09),

2. 6391980 - Activated and conjugated polystyrene substrate (2002-05-21),

3. 6361936 - Activated and conjugated polystyrene substrate (2002-03-26),

4. 6323227 - Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides (2001-11-27),

5. 6307054 - Process for preparing 2,4- dihydroxypyridine and 2,4- dihydroxy-3-nitropyridine (2001-10-23),

6. 6306873 - Substituted &bgr;-thiocarboxylic acids (2001-10-23),

7. 6277865 - Piperididinyl and N-amidinopiperidinyl derivatives (2001-08-21),

8. 6274705 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides (2001-08-14),

9. 6258596 - Variants of apolipoprotein A-I (2001-07-10),

10. 6248841 - Elastomer treatment process to decrease peroxide levels (2001-06-19),

11. 6245760 - Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases (2001-06-12),

12. 6235909 - Preparation of is-[1A,2B,3B,4A(S*)]-4-[7-[[1-(3-chloro-2-Thienyl)methyl]amino]-3H-imidazo [4,5-B]pyridin-3-YL]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide (2001-05-22),

13. 6184382 - Process for preparing N6-substituted adenosine derivatives (2001-02-06),

14. 6180759 - Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides (2001-01-30),

15. 6180632 - Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases (2001-01-30),

Aventis Pharmaceuticals Products Inc. is a leading global pharmaceutical company committed to improving health through innovative medicines. With a diverse product portfolio, we focus on areas such as cardiology, oncology, and rare diseases. Our mission is to provide high-quality medications that meet the needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#18 in Bridgewater, NJ

#560 in New Jersey

#13,951 in US

#26,826 in the World

Bridgewater, NJ, United States of America

Aventis Pharmaceuticals Products Inc.

Forward Citations = 674

70 inventors:

Alfred P Spada (6 out of 52 patents)

Benoit J Vanasse (6 out of 9 patents)

Scott I Klein (5 out of 21 patents)

4. Kevin Richard Guertin (4 out of 16 patents)

5. Adam W Sledeski (3 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…